DSM-Firmenich

DSFIR · Euronext Amsterdam · EUR

€96.16Change from previous close: +0.06%Absolute change: +€0.06

Close · October 2, 2026

At a glance

Revenue growth
−0.22%
2025 vs 2024
Net margin
-12.0%
2024: 2.8%

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Income statement · Annual
Item20252024202320222021
Total revenue9,0349,05410,6278,3907,269
Cost of revenue5,5045,5018,0165,7004,657
Gross profit3,5303,5532,6112,6902,612
Selling, general and administrative2,2092,2072,5351,7721,649
Research and development713814652295274
Operating income629527-560652710
EBIT629527-560652710
EBITDA1,4381,3763451,2341,305
Interest expense15415713810492.0
Pre-tax income460423-654599953
Income tax11864.0-18.0124123
Net income-1,0812502,1371,7001,676
Net income to common shareholders-1,1072222,1311,6941,670
Basic EPS-4.270.849.149.809.67
Diluted EPS-4.270.849.149.779.63
Average shares (basic)259265233173173
Average shares (diluted)259265233173173
Dividend per share2.502.502.502.532.50